T cell receptor (TCR) recognizing human hepatitis b virus (HBV) antigen and use thereof
The invention belongs to the field of biological medicine, and particularly relates to a T cell receptor (TCR) for recognizing human hepatitis B virus (HBV) antigen and application thereof. Specifically, the T cell antigen receptor (TCR) comprises CDR1, CDR2 and CDR3 of an alpha chain and CDR1, CDR2...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention belongs to the field of biological medicine, and particularly relates to a T cell receptor (TCR) for recognizing human hepatitis B virus (HBV) antigen and application thereof. Specifically, the T cell antigen receptor (TCR) comprises CDR1, CDR2 and CDR3 of an alpha chain and CDR1, CDR2 and CDR3 of a beta chain, the amino acid sequences of the CDR1, the CDR2 and the CDR3 of the alpha chain are as shown in SEQ ID No. 2 to 4, SEQ ID No. 15 to 17, SEQ ID No. 23 to 25 or SEQ ID No. 31 to 33; the amino acid sequences of the CDR1, the CDR2 and the CDR3 of the beta chain are shown as SEQ ID No. 5 to 7, SEQ ID No. 18 to 20, SEQ ID No. 26 to 28 or SEQ ID No. 34 to 36 in sequence.
本发明属于生物医药领域,具体涉及识别人乙型肝炎病毒(HBV)抗原的T细胞受体(TCR)及其用途。具体地,本发明所述T细胞抗原受体(TCR)包括α链的CDR1、CDR2和CDR3以及β链的CDR1、CDR2和CDR3;所述α链的CDR1、CDR2、CDR3的氨基酸序列如SEQ ID No.2-4、SEQ ID NO.15-17、SEQ ID NO.23-25或SEQ ID NO.31-33所示;所述β链的CDR1、CDR2、CDR3的氨基酸序列依次如SEQ ID No.5-7、SEQ NO.18-20、SEQ NO.26-28或SEQ NO.34-36所示。 |
---|